Narcotics Enforcement Division

3375 Koapaka Street, Suite D-100
Honolulu, Hawaii 96819
Phone: 837-8470
Fax: 837-8474
E-mail: [email protected]

FORM REQUIRED FOR PRACTITIONER, APRN, AND PA RENEWALS:

PRINT YOUR CERTIFICATE ONLINE

Effective January 1, 2024, you must retrieve and print your controlled substance certificate via your NED Self-Service Portal

GO TO: https://ned.ehawaii.gov/portal

Log in using your existing eHawaii.gov account. Obtain your certificate through the “My Registration” tab.

Federal Scheduling Actions 2018-2020

2018 and 2019 NEW & CHANGES TO THE LAW

Act 95 2019/SB 1263 Amends the Uniform Controlled Substance Act by updating Schedule V and amending requirements for electronic prescriptions, for consistency with federal law.
Act 230 2019/SB1486 Amends Electronic Prescription Accountability system (HI-PDMP)
Act 251 2019/HB665 Exceptions to query of Electronic Prescription Accountability System (HI-PDMP)
Act 256 2019/SB536 Prescription requirements related to schedule II drugs
Act 95 2019/SB 1263 Addition of FDA approved CBD drugs to Schedule V
Act 066/Senate Bill 505(2017) Effective 07-01-18. Requirement for policy or and written agreements to engage in an informed consent process between the prescribing provider and qualifying opioid therapy patient. Related Resource: Hawaii Department of Health, Patient Informed Consent Form also the Hawaii Revised Statute (HRS) 329.38-5
Act 151/House Bill 1602 Effective 08-01-18. Requires the inclusion of a label warning of the risks of addiction and death on the packaging of any opioid drug dispensed by a health care professional or pharmacist.
Act 153/Senate Bill 2646 Effective 07-01-18 Pertains to practitioner utilization requirements of the PDMP
Act 190/House Bill 2385 Effective 07-01-18. Relating to scheduling actions of substituted cathinones, cumyl-4-cn-binaca and dronabinol